Publications

Detailed Information

Wnt inhibitory factor (WIF)-1 inhibits osteoblastic differentiation in mouse embryonic mesenchymal cells

DC Field Value Language
dc.contributor.authorCho, Sun Wook-
dc.contributor.authorYang, Jae-Yeon-
dc.contributor.authorSun, Hyun Jin-
dc.contributor.authorJung, Ju Yeon-
dc.contributor.authorCho, Hwa Young-
dc.contributor.authorKim, Sang Wan-
dc.contributor.authorShin, Chan Soo-
dc.contributor.authorKim, Seong Yeon-
dc.contributor.authorChoi, Hyung Jin-
dc.contributor.authorHer, Sun Ju-
dc.date.accessioned2012-05-25T00:51:14Z-
dc.date.available2012-05-25T00:51:14Z-
dc.date.issued2009-06-
dc.identifier.citationBONE; Vol.44 6; 1069-1077ko_KR
dc.identifier.issn8756-3282-
dc.identifier.urihttps://hdl.handle.net/10371/76446-
dc.description.abstractWnt inhibitory factor (WIF)-1 belongs to the members of secreted modulators of Wnt proteins. Secreted frizzled-related proteins (sFRPs), another member of Wnt modulators, have been shown to play differential roles in Writ signaling depending on the subtypes and cell models. This Study was undertaken to investigate the functional role of WIF-1 in osteoblastic differentiation of mouse mesenchymal C3H10T1/2 cells. C3H10T1/2 cells express endogenous WIF-1 and its expression level decreases during osteoblastogenesis. Treatment of C3H10T1/2 cells with WIF-1 significantly reduced alkaline phosphatase (ALP) activities induced by either osteogenic medium (OM, ascorbic acid and beta-glycerophosphate) or Wnt-3a conditioned medium (CM) in a dose-dependent manner. In contrast, the expression level of endogenous WIF-1 increased during adipogenesis and WIF-1 treatment resulted in increased adipogenesis. C3H10T1/2 cells transduced with WIF-1 retrovirus also exhibited reduced ALP activity and decreased mRNA expression of Runx2, collagen type 1, ALP and cisteocalcin during osteoblastic differentiation compared to empty virus-transduced cells. Moreover, treatment with WIF-1 dose-dependently attenuates beta-catenin/T-cell factor (TCF) transcriptional activity in this cell line. Finally, knockdown of WIF-1 in C3H10T1/2 cells by RNA interference leads to increase in ALP activities. Collectively, these results indicate that WIF-1 plays as a negative regulator of osteoblastic differentiation in mouse mesenchymal C3H10T1/2 cells in vitro. (C) 2009 Elsevier Inc. All rights reserved.ko_KR
dc.language.isoenko_KR
dc.publisherELSEVIER SCIENCE INCko_KR
dc.subjectWnt inhibitory factor-1ko_KR
dc.subjectAdipogenesisko_KR
dc.subjectMesenchymal cellko_KR
dc.subjectOsteoblastic differentiationko_KR
dc.subjectWntko_KR
dc.titleWnt inhibitory factor (WIF)-1 inhibits osteoblastic differentiation in mouse embryonic mesenchymal cellsko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor조선욱-
dc.contributor.AlternativeAuthor양재연-
dc.contributor.AlternativeAuthor선현진-
dc.contributor.AlternativeAuthor정주연-
dc.contributor.AlternativeAuthor허선주-
dc.contributor.AlternativeAuthor조화영-
dc.contributor.AlternativeAuthor최형진-
dc.contributor.AlternativeAuthor김상완-
dc.contributor.AlternativeAuthor김성연-
dc.contributor.AlternativeAuthor신찬수-
dc.identifier.doi10.1016/j.bone.2009.02.012-
dc.citation.journaltitleBONE-
dc.description.citedreferenceCho SW, 2008, BIOCHEM BIOPH RES CO, V367, P399, DOI 10.1016/j.bbrc.2007.12.128-
dc.description.citedreferenceLi X, 2007, J BONE MINER RES, V22, pS65-
dc.description.citedreferenceYaccoby S, 2007, BLOOD, V109, P2106, DOI 10.1182/blood-2006-09-047712-
dc.description.citedreferenceBodine PVN, 2006, REV ENDOCR METAB DIS, V7, P33, DOI 10.1007/s11154-006-9002-4-
dc.description.citedreferenceYang LJ, 2006, J DERMATOL SCI, V42, P111, DOI 10.1016/j.jdermsci.2005.12.011-
dc.description.citedreferenceGalli LM, 2006, DEV DYNAM, V235, P681, DOI 10.1002/dvdy.20681-
dc.description.citedreferenceNakashima A, 2005, J BIOL CHEM, V280, P37660, DOI 10.1074/jbc.M504612200-
dc.description.citedreferencevan der Horst G, 2005, J BONE MINER RES, V20, P1867, DOI 10.1359/JBMR.050614-
dc.description.citedreferenceHolmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907-
dc.description.citedreferenceReguart N, 2004, BIOCHEM BIOPH RES CO, V323, P229, DOI 10.1016/j.bbrc.2004.08.075-
dc.description.citedreferenceChung YS, 2004, J BONE MINER RES, V19, P1395, DOI 10.1359/JBMR.040412-
dc.description.citedreferenceNuttall ME, 2004, CURR OPIN PHARMACOL, V4, P290, DOI 10.1016/j.coph.2004.03.002-
dc.description.citedreferenceHe X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117-
dc.description.citedreferenceRawadi G, 2003, J BONE MINER RES, V18, P1842-
dc.description.citedreferenceBabij P, 2003, J BONE MINER RES, V18, P960-
dc.description.citedreferenceVaes BLT, 2002, J BONE MINER RES, V17, P2106-
dc.description.citedreferenceBennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200-
dc.description.citedreferenceMao BY, 2002, NATURE, V417, P664-
dc.description.citedreferenceLittle RD, 2002, AM J HUM GENET, V70, P11-
dc.description.citedreferenceGong YQ, 2001, CELL, V107, P513-
dc.description.citedreferenceFurlan F, 2001, CELL COMMUN ADHES, V8, P367-
dc.description.citedreferenceEllies DL, 2000, DEVELOPMENT, V127, P5285-
dc.description.citedreferenceHsieh JC, 1999, NATURE, V398, P431-
dc.description.citedreferencePolakis P, 1999, CURR OPIN GENET DEV, V9, P15-
dc.description.citedreferenceShibamoto S, 1998, GENES CELLS, V3, P659-
dc.description.citedreferenceCadigan KM, 1997, GENE DEV, V11, P3286-
dc.description.citedreferenceMelkonyan HS, 1997, P NATL ACAD SCI USA, V94, P13636-
dc.description.citedreferenceShimizu H, 1997, CELL GROWTH DIFFER, V8, P1349-
dc.description.citedreferenceWang SW, 1997, CELL, V88, P757-
dc.description.citedreferenceNUSSE R, 1982, CELL, V31, P99-
dc.description.tc11-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share